Lesson series

Translation 1: Product Development

Product Development first involves defining what the product is and understanding how it will compete in the marketplace. This module explains key steps taken in developing a Product Proposition and then addresses fundamental considerations in the development of a robust manufacturing process. This module will outline and build an understanding of the importance of defining what the product is and how it will compete in the marketplace, development of the Product Proposition and Target Product Profile Considerations of Product Development, key steps taken to demonstrate a safe and effective product and considerations in the development of a robust process. 

Write your awesome label here.

6 Topics

Across hours of online content

7 Case Studies

Direct from industry

4 Quizzes

Check your knowledge

1 Assessment

Complete the course

1 Q&A Webinar

Live session with a CBE Expert
Normal text with icon

Supplementary Learning Materials

Videos, resources, useful reading, links and examples

Who is this course for?

CBE’s Translation Uplift program is designed to uplift participants knowledge in product realisation, technical elements that support translating an asset from R&D into the clinic and then ultimately as a commercial product. 

Senior Managers

The skill you need to become a real professional.

Researchers

Learn the tools used by the world's top professionals.

Regulatory Affairs

Boost your confidence, master "the field".

Meet your trainers for this course

Our trainers have decades of industry knowledge, technical expertise and practical experience across all aspects of the biopharmaceutical sector. 

Rachel Jensen

Course Trainer

Rachel Jensen has over 20 years of experience across the biotech industry in commercial operations, strategic compliance and business management. As a Director at CBE, she provides specialised consulting services that assist organisations with strategy and commercial development.

Jeff Davies

Course Trainer

With more than 30 years of leadership across the biopharmaceutical industry, Jeff was CSL’s Executive Vice President and GM Asia Pacific. He also had oversight of plasma products, influenza vaccines, anti-venoms, in licensed vaccines and pharmaceuticals as well as the diagnostic product business.